Biohaven (BHVN) Financials

$18.39 -0.12 (-0.65%)

As of 01:58 PM Eastern

Annual Income Statements for Biohaven

This table shows Biohaven's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-119	-214	-570	-408	-846
Consolidated Net Income / (Loss)	-119	-214	-570	-408	-846
Net Income / (Loss) Continuing Operations	-119	-214	-570	-408	-846
Total Pre-Tax Income	-119	-212	-570	-410	-846
Total Operating Income	-115	-219	-568	-436	-885
Total Gross Profit	0.00	0.00	0.00	0.00	0.00
Total Revenue	0.00	0.00	0.00	0.00	0.00
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Total Operating Expenses	115	219	568	436	885
Selling, General & Admin Expense	16	37	131	63	89
Research & Development Expense	98	181	437	373	796
Total Other Income / (Expense), net	-4.16	6.47	-1.91	27	39
Other Income / (Expense), net	0.00	1.21	-1.91	27	39
Income Tax Expense	0.00	1.37	0.44	-1.38	0.74
Basic Earnings per Share	($3.01)	($5.43)	($12.75)	($5.73)	($9.28)
Weighted Average Basic Shares Outstanding	39.38M	39.38M	44.74M	71.20M	91.23M
Diluted Earnings per Share	($3.01)	($5.43)	($12.75)	($5.73)	($9.28)
Weighted Average Diluted Shares Outstanding	39.38M	39.38M	44.74M	71.20M	91.23M
Weighted Average Basic & Diluted Shares Outstanding	-	-	68.21M	81.58M	102.05M

This table shows Biohaven's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-69	-201	-70	-90	-102	-145	-180	-320	-160	-187
Consolidated Net Income / (Loss)	-69	-201	-70	-90	-103	-145	-180	-320	-160	-187
Net Income / (Loss) Continuing Operations	-69	-201	-70	-90	-103	-145	-180	-320	-160	-187
Total Pre-Tax Income	-68	-215	-70	-88	-106	-146	-179	-320	-160	-187
Total Operating Income	-68	-213	-78	-94	-111	-154	-183	-334	-178	-190
Total Operating Expenses	68	213	78	94	111	154	183	334	178	190
Selling, General & Admin Expense	15	76	14	15	15	19	27	19	21	22
Research & Development Expense	53	137	63	79	96	135	156	315	158	167
Total Other Income / (Expense), net	0.00	-1.84	8.23	5.84	4.69	7.74	4.31	14	18	3.14
Income Tax Expense	1.22	-14	0.94	2.18	-3.29	-1.21	0.57	0.18	-0.06	0.05
Basic Earnings per Share	($1.75)	($3.38)	($1.03)	($1.32)	($1.50)	($1.88)	($2.20)	($3.64)	($1.70)	($1.74)
Weighted Average Basic Shares Outstanding	39.38M	44.74M	68.21M	68.25M	68.32M	71.20M	81.60M	87.77M	94.37M	91.23M
Diluted Earnings per Share	($1.75)	($3.38)	($1.03)	($1.32)	($1.50)	($1.88)	($2.20)	($3.64)	($1.70)	($1.74)
Weighted Average Diluted Shares Outstanding	39.38M	44.74M	68.21M	68.25M	68.32M	71.20M	81.60M	87.77M	94.37M	91.23M
Weighted Average Basic & Diluted Shares Outstanding	-	68.21M	68.22M	68.32M	80.23M	81.58M	88.29M	94.54M	101.12M	102.05M

This table details how cash moves in and out of Biohaven's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	74	-6.45	166	9.52	-150
Net Cash From Operating Activities	-76	-146	-298	-332	-582
Net Cash From Continuing Operating Activities	-76	-146	-298	-332	-582
Net Income / (Loss) Continuing Operations	-119	-214	-570	-408	-846
Consolidated Net Income / (Loss)	-119	-214	-570	-408	-846
Depreciation Expense	0.07	1.39	1.39	6.91	7.86
Non-Cash Adjustments To Reconcile Net Income	34	65	300	45	239
Changes in Operating Assets and Liabilities, net	8.98	1.66	-29	25	17
Net Cash From Investing Activities	-2.70	0.94	-305	130	-245
Net Cash From Continuing Investing Activities	-2.70	0.94	-305	130	-245
Purchase of Property, Plant & Equipment	-1.10	-0.94	-6.07	-3.05	-4.05
Acquisitions	0.00	1.88	-35	0.00	0.39
Purchase of Investments	0.00	0.00	-260	-194	-746
Sale and/or Maturity of Investments	-	0.00	0.00	327	504
Other Investing Activities, net	-1.60	0.00	-4.00	0.00	0.00
Net Cash From Financing Activities	152	138	768	212	678
Net Cash From Continuing Financing Activities	152	138	768	212	678
Repayment of Debt	0.00	-	0.00	0.00	2.26
Repurchase of Common Equity	0.00	0.00	-1.00	-0.80	-2.15
Issuance of Common Equity	92	138	733	248	678
Other Financing Activities, net	60	0.00	35	-35	0.00
Effect of Exchange Rate Changes	0.00	0.00	0.43	-0.50	0.08
Cash Interest Paid	0.00	0.11	0.00	0.00	0.13
Cash Income Taxes Paid	2.76	17	38	-33	-10

This table details how cash moves in and out of Biohaven's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	27	191	-52	11	-76	126	-65	55	-154	15
Net Cash From Operating Activities	-96	-75	-78	-44	-95	-115	-103	-168	-141	-171
Net Cash From Continuing Operating Activities	-96	-75	-78	-44	-95	-115	-103	-168	-141	-171
Net Income / (Loss) Continuing Operations	-69	-201	-70	-90	-103	-145	-180	-320	-160	-187
Consolidated Net Income / (Loss)	-69	-201	-70	-90	-103	-145	-180	-320	-160	-187
Depreciation Expense	0.38	0.34	1.65	1.83	1.54	1.89	1.45	1.95	1.99	2.46
Non-Cash Adjustments To Reconcile Net Income	17	126	2.02	2.76	3.44	37	50	173	-3.48	20
Changes in Operating Assets and Liabilities, net	-44	-1.00	-11	41	2.78	-8.72	26	-23	21	-6.02
Net Cash From Investing Activities	-4.52	-264	-1.06	76	59	-3.91	34	-98	-93	-88
Net Cash From Continuing Investing Activities	-4.52	-264	-1.06	76	59	-3.91	34	-98	-93	-88
Purchase of Property, Plant & Equipment	-4.52	-0.30	-0.74	-0.60	-1.25	-0.47	-0.44	-2.95	-0.61	-0.05
Purchase of Investments	-	-260	-30	-24	-29	-111	-47	-196	-223	-280
Sale and/or Maturity of Investments	-	-	29	100	89	108	81	101	130	192
Net Cash From Financing Activities	128	530	27	-20	-40	245	3.42	321	80	273
Net Cash From Continuing Financing Activities	128	530	27	-20	-40	245	3.42	321	80	273
Repurchase of Common Equity	-	-	-	-	-	-0.80	-	-	-	-1.35
Issuance of Common Equity	128	496	-	-	-	248	-	-	76	283
Other Financing Activities, net	-	35	27	-20	-42	-0.03	2.20	2.37	4.01	-8.58
Effect of Exchange Rate Changes	-	0.43	0.02	-0.16	-0.04	-0.31	-0.01	-0.01	-	0.09

This table presents Biohaven's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Total Assets	142	662	513	615
Total Current Assets	95	587	442	538
Cash & Equivalents	76	205	248	99
Short-Term Investments	0.00	260	133	387
Prepaid Expenses	6.73	21	35	49
Current Deferred & Refundable Income Taxes	9.91	46	13	2.60
Other Current Assets	2.12	19	12	0.51
Plant, Property, & Equipment, net	13	18	17	17
Total Noncurrent Assets	34	57	54	59
Goodwill	1.39	1.39	1.39	1.39
Intangible Assets	18	18	18	18
Other Noncurrent Operating Assets	14	38	34	40
Total Liabilities & Shareholders' Equity	142	662	513	615
Total Liabilities	47	123	85	192
Total Current Liabilities	42	90	55	154
Accounts Payable	4.78	11	16	18
Accrued Expenses	37	44	40	51
Other Current Liabilities	0.00	35	0.00	85
Total Noncurrent Liabilities	5.44	33	30	37
Other Noncurrent Operating Liabilities	5.44	33	30	37
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	35	539	428	423
Total Preferred & Common Equity	35	539	428	423
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	35	539	428	423
Common Stock	0.00	630	927	1,769
Retained Earnings	0.00	-91	-499	-1,346
Accumulated Other Comprehensive Income / (Loss)	0.00	0.28	-0.07	0.08

This table presents Biohaven's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	619	507	383	419	583	511
Total Current Assets	544	434	311	349	511	441
Cash & Equivalents	125	148	112	183	239	84
Short-Term Investments	263	188	129	101	198	294
Prepaid Expenses	26	28	34	46	60	55
Current Deferred & Refundable Income Taxes	44	8.66	13	8.43	7.52	5.32
Other Current Assets	25	22	23	11	7.27	1.20
Plant, Property, & Equipment, net	17	17	18	17	19	18
Total Noncurrent Assets	57	55	54	53	53	52
Goodwill	1.39	1.39	1.39	1.39	1.39	1.39
Intangible Assets	18	18	18	18	18	18
Other Noncurrent Operating Assets	37	36	35	33	33	32
Total Liabilities & Shareholders' Equity	619	507	383	419	583	511
Total Liabilities	146	119	93	117	199	195
Total Current Liabilities	114	88	62	87	156	152
Accounts Payable	14	12	9.52	36	17	20
Accrued Expenses	38	35	53	50	58	64
Other Current Liabilities	62	40	0.03	-	81	69
Total Noncurrent Liabilities	32	32	31	30	43	42
Other Noncurrent Operating Liabilities	32	32	31	30	43	42
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	472	387	290	301	384	316
Total Preferred & Common Equity	472	387	290	301	384	316
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	472	387	290	301	384	316
Common Stock	634	639	644	980	1,382	1,475
Retained Earnings	-162	-252	-355	-679	-999	-1,159
Accumulated Other Comprehensive Income / (Loss)	0.17	0.02	0.16	-0.11	-0.08	0.14

This table displays calculated financial ratios and metrics derived from Biohaven's official financial filings.

Metric	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	0.00%	-89.02%	-162.81%	29.17%	-108.09%
EBIT Growth	0.00%	-90.11%	-161.77%	28.13%	-106.49%
NOPAT Growth	0.00%	-91.17%	-159.45%	23.22%	-102.98%
Net Income Growth	0.00%	-80.16%	-166.74%	28.43%	-107.37%
EPS Growth	0.00%	-80.40%	-134.81%	55.06%	-61.95%
Operating Cash Flow Growth	0.00%	-92.00%	-104.12%	-11.43%	-75.58%
Free Cash Flow Firm Growth	0.00%	0.00%	-142.71%	24.92%	-63.13%
Invested Capital Growth	0.00%	0.00%	105.10%	20.77%	-235.53%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	14.96%	0.45%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	14.47%	0.38%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	12.04%	-4.27%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	12.13%	-5.23%
EPS Q/Q Growth	0.00%	0.00%	0.00%	20.75%	1.49%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	-13.51%	-10.61%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-5.98%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-6.53%	0.41%
Profitability Metrics	-	-	-	-	-
Gross Margin	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Tax Burden Percent	100.00%	100.64%	100.08%	99.66%	100.09%
Interest Burden Percent	103.63%	97.58%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	0.00%	-225.78%	-180.05%	-84.44%	-198.83%
Cash Return on Invested Capital (CROIC)	0.00%	-1,844.63%	-1,467.45%	-742.35%	0.00%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	0.00%	-82.72%	-163.00%	-84.44%	-198.83%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-616.29%	-105.85%	-95.37%	-199.89%
Net Operating Profit after Tax (NOPAT)	-80	-153	-398	-305	-620
NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	0.00%	-159.26%	-59.91%	-23.33%	-52.28%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-73.79%	-71.32%	-146.32%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	-115	-218	-570	-410	-846
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-114	-216	-568	-403	-838
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	0.00	161.51	1.76	6.82	6.01
Price to Tangible Book Value (P/TBV)	0.00	376.01	1.82	7.15	6.31
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	299.82	11.66	54.93	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.00	-0.80	-0.91	-0.91	-1.02
Leverage Ratio	0.00	1.50	1.27	1.22	1.33
Compound Leverage Factor	0.00	1.46	1.27	1.22	1.33
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	63.36%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	36.64%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	66.36	2.48	17.44	1.12
Noncontrolling Interest Sharing Ratio	0.00%	63.36%	9.47%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	0.00	2.26	6.52	7.98	3.49
Quick Ratio	0.00	1.81	5.17	6.89	3.15
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-172	-417	-313	-511
Operating Cash Flow to CapEx	-6,924.07%	-15,547.97%	-4,901.04%	-10,883.37%	-14,385.11%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	0.00	19	38	46	-63
Invested Capital Turnover	0.00	0.00	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	0.00	19	20	7.94	-109
Enterprise Value (EV)	0.00	5,587	446	2,535	2,060
Market Capitalization	0.00	5,603	946	2,917	2,546
Book Value per Share	$0.00	$0.88	$12.04	$5.33	$4.19
Tangible Book Value per Share	$0.00	$0.38	$11.60	$5.09	$3.99
Total Capital	0.00	95	539	428	423
Total Debt	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Net Debt	0.00	-76	-501	-382	-486
Capital Expenditures (CapEx)	1.10	0.94	6.07	3.05	4.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-23	-3.61	5.20	-102
Debt-free Net Working Capital (DFNWC)	0.00	53	497	387	384
Net Working Capital (NWC)	0.00	53	497	387	384
Net Nonoperating Expense (NNE)	39	61	173	103	227
Net Nonoperating Obligations (NNO)	0.00	-76	-501	-382	-486
Total Depreciation and Amortization (D&A)	0.07	1.39	1.39	6.91	7.86
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($12.75)	($5.73)	($9.28)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	44.74M	71.20M	91.23M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($12.75)	($5.73)	($9.28)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	44.74M	71.20M	91.23M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	68.21M	81.58M	102.05M
Normalized Net Operating Profit after Tax (NOPAT)	-80	-153	-398	-305	-620
Normalized NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Pre Tax Income Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-0.18%	-0.20%	-0.25%

This table displays calculated financial ratios and metrics derived from Biohaven's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	0.00%	0.00%	24.15%	56.12%	-55.10%	32.96%	-161.38%	-284.32%	-51.81%	-30.12%
EBIT Growth	0.00%	0.00%	22.53%	55.28%	-56.51%	32.19%	-157.26%	-278.56%	-51.48%	-30.12%
NOPAT Growth	0.00%	0.00%	13.36%	52.31%	-63.44%	27.97%	-135.58%	-255.04%	-61.17%	-23.56%
Net Income Growth	0.00%	0.00%	27.35%	55.56%	-48.98%	28.02%	-154.64%	-253.94%	-56.28%	-29.07%
EPS Growth	0.00%	0.00%	58.13%	74.42%	14.29%	44.38%	-113.59%	-175.76%	-13.33%	7.45%
Operating Cash Flow Growth	0.00%	0.00%	-31.96%	34.61%	0.78%	-52.35%	-32.20%	-277.98%	-49.00%	-48.63%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-60.27%	-117.60%	90.12%	79.02%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	20.77%	-20.51%	-553.80%	-227.19%	-235.53%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	65.82%	-219.52%	68.40%	-27.15%	-20.83%	-38.10%	-23.19%	-86.95%	52.27%	-18.38%
EBIT Q/Q Growth	65.70%	-218.24%	67.69%	-26.77%	-20.07%	-37.89%	-22.59%	-86.53%	51.95%	-18.44%
NOPAT Q/Q Growth	65.69%	-215.53%	63.55%	-20.86%	-17.59%	-39.05%	-19.21%	-82.15%	46.62%	-6.60%
Net Income Q/Q Growth	66.13%	-192.08%	64.95%	-28.16%	-13.53%	-41.12%	-24.00%	-78.14%	49.87%	-16.56%
EPS Q/Q Growth	66.09%	-93.14%	69.53%	-28.16%	-13.64%	-25.33%	-17.02%	-65.45%	53.30%	-2.35%
Operating Cash Flow Q/Q Growth	-40.77%	21.09%	-2.96%	42.82%	-113.58%	-21.17%	10.66%	-63.49%	15.81%	-20.86%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-0.52%	-63.50%	8.86%	-6.99%	-36.48%	92.58%	-93.53%
Invested Capital Q/Q Growth	0.00%	0.00%	-40.65%	-48.30%	321.17%	-6.53%	-60.94%	-395.12%	-18.05%	0.41%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Tax Burden Percent	101.80%	93.43%	101.35%	102.47%	96.90%	99.17%	100.32%	100.06%	99.96%	100.03%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	95.75%	100.00%	98.35%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	0.00%	-180.05%	-115.14%	-111.24%	-160.18%	-84.44%	-133.69%	-193.67%	-265.45%	-198.83%
Cash Return on Invested Capital (CROIC)	0.00%	-1,091.47%	0.00%	0.00%	0.00%	-742.35%	-1,839.37%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	0.00%	-163.00%	-115.14%	-111.24%	-160.18%	-84.44%	-133.69%	-193.67%	-265.45%	-198.83%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-115.14%	-111.24%	-160.18%	0.00%	-171.57%	-194.56%	-254.53%	0.00%
Net Operating Profit after Tax (NOPAT)	-47	-149	-54	-66	-77	-108	-128	-234	-125	-133
NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	0.00%	-10.33%	-7.14%	-13.07%	-20.94%	-8.42%	-13.98%	-21.20%	-11.49%	-12.42%
Return On Investment Capital (ROIC_SIMPLE)	-	-27.73%	-	-	-	-25.14%	-	-	-	-31.40%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	-68	-215	-70	-88	-106	-146	-179	-334	-160	-190
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-67	-215	-68	-86	-104	-144	-177	-332	-158	-187
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	1.76	1.97	4.21	6.11	6.82	12.37	6.17	10.78	6.01
Price to Tangible Book Value (P/TBV)	0.00	1.82	2.06	4.44	6.56	7.15	13.24	6.50	11.50	6.31
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	11.66	21.23	107.03	31.03	54.93	191.04	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.00	-0.93	-0.95	-0.97	-0.83	-0.91	-0.95	-1.05	-1.02	-1.02
Leverage Ratio	0.00	1.27	1.31	1.31	1.32	1.22	1.34	1.41	1.47	1.33
Compound Leverage Factor	0.00	1.27	1.31	1.31	1.32	1.22	1.34	1.35	1.47	1.30
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	4.25	3.92	7.74	10.04	19.14	16.17	3.58	6.97	4.64
Noncontrolling Interest Sharing Ratio	0.00%	9.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	6.52	4.78	4.94	4.99	7.98	4.03	3.27	2.89	3.49
Quick Ratio	0.00	5.17	3.40	3.81	3.87	6.89	3.27	2.80	2.49	3.15
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	-77	-78	-127	-116	-124	-169	-13	-24
Operating Cash Flow to CapEx	-2,112.29%	-25,135.67%	-10,562.99%	-7,461.01%	-7,597.20%	-24,442.77%	-23,326.59%	-5,690.00%	-23,122.09%	-348,453.06%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	38	23	12	49	46	18	-53	-63	-63
Invested Capital Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	0.00	0.00	23	12	49	7.94	-4.65	-65	-112	-109
Enterprise Value (EV)	0.00	446	482	1,255	1,532	2,535	3,444	1,929	3,027	2,060
Market Capitalization	248	946	931	1,630	1,773	2,917	3,728	2,366	3,406	2,546
Book Value per Share	$0.00	$12.04	$6.92	$5.68	$4.25	$5.33	$3.70	$4.35	$3.34	$4.19
Tangible Book Value per Share	$0.00	$11.60	$6.63	$5.39	$3.96	$5.09	$3.45	$4.12	$3.13	$3.99
Total Capital	0.00	539	472	387	290	428	301	384	316	423
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	0.00	-501	-450	-376	-241	-382	-283	-437	-379	-486
Capital Expenditures (CapEx)	4.52	0.30	0.74	0.60	1.25	0.47	0.44	2.95	0.61	0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-3.61	-19	-29	7.77	5.20	-21	-82	-91	-102
Debt-free Net Working Capital (DFNWC)	0.00	497	430	346	248	387	262	355	288	384
Net Working Capital (NWC)	0.00	497	430	346	248	387	262	355	288	384
Net Nonoperating Expense (NNE)	22	52	16	25	25	37	51	86	36	54
Net Nonoperating Obligations (NNO)	0.00	-501	-450	-376	-241	-382	-283	-437	-379	-486
Total Depreciation and Amortization (D&A)	0.38	0.34	1.65	1.83	1.54	1.89	1.45	1.95	1.99	2.46
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($3.38)	($1.03)	($1.32)	($1.50)	($1.88)	($2.20)	($3.64)	($1.70)	($1.74)
Adjusted Weighted Average Basic Shares Outstanding	0.00	44.74M	68.21M	68.25M	68.32M	71.20M	81.60M	87.77M	94.37M	91.23M
Adjusted Diluted Earnings per Share	$0.00	($3.38)	($1.03)	($1.32)	($1.50)	($1.88)	($2.20)	($3.64)	($1.70)	($1.74)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	44.74M	68.21M	68.25M	68.32M	71.20M	81.60M	87.77M	94.37M	91.23M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	68.21M	68.22M	68.32M	80.23M	81.58M	88.29M	94.54M	101.12M	102.05M
Normalized Net Operating Profit after Tax (NOPAT)	-47	-149	-54	-66	-77	-108	-128	-234	-125	-133
Normalized NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Pre Tax Income Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-0.18%	0.00%	0.00%	0.00%	-0.20%	0.00%	-0.21%	-0.20%	-0.25%

Frequently Asked Questions About Biohaven's Financials

When does Biohaven's financial year end?

According to the most recent income statement we have on file, Biohaven's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Biohaven's net income changed over the last 4 years?

Biohaven's net income appears to be on an upward trend, with a most recent value of -$846.42 million in 2024, rising from -$118.67 million in 2020. The previous period was -$408.17 million in 2023.

What is Biohaven's operating income?

Biohaven's total operating income in 2024 was -$885.11 million, based on the following breakdown:

Total Gross Profit: $0.00
Total Operating Expenses: $885.11 million

How has Biohaven revenue changed over the last 4 years?

Over the last 4 years, Biohaven's total revenue changed from $0.00 in 2020 to $0.00 in 2024, a change of 0.0%.

How much debt does Biohaven have?

Biohaven's total liabilities were at $191.67 million at the end of 2024, a 124.9% increase from 2023, and a 304.6% increase since 2021.

How much cash does Biohaven have?

In the past 3 years, Biohaven's cash and equivalents has ranged from $76.06 million in 2021 to $248.40 million in 2023, and is currently $99.13 million as of their latest financial filing in 2024.

How has Biohaven's book value per share changed over the last 4 years?

Over the last 4 years, Biohaven's book value per share changed from 0.00 in 2020 to 4.19 in 2024, a change of 418.7%.

Remove Ads

Related Companies

This page (NYSE:BHVN) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biohaven (BHVN) Financials

Frequently Asked Questions About Biohaven's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biohaven (BHVN) Financials

Annual Income Statements for Biohaven

Quarterly Income Statements for Biohaven

Annual Cash Flow Statements for Biohaven

Quarterly Cash Flow Statements for Biohaven

Annual Balance Sheets for Biohaven

Quarterly Balance Sheets for Biohaven

Annual Metrics and Ratios for Biohaven

Quarterly Metrics and Ratios for Biohaven

Frequently Asked Questions About Biohaven's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools